BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8881091)

  • 1. Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia.
    Bouchard S; Gauthier J; Laberge B; French D; Pelletier MH; Godbout C
    Behav Res Ther; 1996 Mar; 34(3):213-24. PubMed ID: 8881091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interoceptive exposure versus breathing retraining within cognitive-behavioural therapy for panic disorder with agoraphobia.
    Craske MG; Rowe M; Lewin M; Noriega-Dimitri R
    Br J Clin Psychol; 1997 Feb; 36(1):85-99. PubMed ID: 9051281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panic control treatment for agoraphobia.
    Craske MG; DeCola JP; Sachs AD; Pontillo DC
    J Anxiety Disord; 2003; 17(3):321-33. PubMed ID: 12727125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia.
    van den Hout M; Arntz A; Hoekstra R
    Behav Res Ther; 1994 May; 32(4):447-51. PubMed ID: 7910732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia.
    Ost LG; Westling BE; Hellström K
    Behav Res Ther; 1993 May; 31(4):383-94. PubMed ID: 8099789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability.
    Williams SL; Falbo J
    Behav Res Ther; 1996 Mar; 34(3):253-64. PubMed ID: 8881094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group cognitive-behavioral treatment of panic disorder.
    Telch MJ; Lucas JA; Schmidt NB; Hanna HH; LaNae Jaimez T; Lucas RA
    Behav Res Ther; 1993 Mar; 31(3):279-87. PubMed ID: 8476402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of telephone-administered behavioral therapy for panic disorder with agoraphobia.
    Swinson RP; Fergus KD; Cox BJ; Wickwire K
    Behav Res Ther; 1995 May; 33(4):465-9. PubMed ID: 7755536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioral group psychotherapy for agoraphobia and panic disorder.
    Belfer PL; Munoz LS; Schachter J; Levendusky PG
    Int J Group Psychother; 1995 Apr; 45(2):185-206. PubMed ID: 7759179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of personality disorders on response to cognitive behavioral therapy of panic disorder with agoraphobia].
    Marchand A; Wapler M
    Can J Psychiatry; 1993 Apr; 38(3):163-6. PubMed ID: 8500066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of panic disorder with agoraphobia treated by exposure.
    Fava GA; Rafanelli C; Grandi S; Conti S; Ruini C; Mangelli L; Belluardo P
    Psychol Med; 2001 Jul; 31(5):891-8. PubMed ID: 11459386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belief disconfirmation versus habituation approaches to situational exposure in panic disorder with agoraphobia: a pilot study.
    Salkovskis PM; Hackmann A; Wells A; Gelder MG; Clark DM
    Behav Res Ther; 2007 May; 45(5):877-85. PubMed ID: 17296165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of different variables on the outcome of various cognitive-behavioral treatment modalities for panic disorder with agoraphobia].
    Marchand A; Germain V
    Encephale; 2004; 30(6):548-56. PubMed ID: 15738857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia.
    Spiegel DA; Roth M; Weissman M; Lavori P; Gorman J; Rush J; Ballenger J
    Br J Psychiatry; 1993 Jun; 162():788-9; discussion 790-4. PubMed ID: 8101127
    [No Abstract]   [Full Text] [Related]  

  • 17. Does exposure to internal cues enhance exposure to external cues in agoraphobia with panic? A pilot controlled study of self-exposure.
    Ito LM; Noshirvani H; Başoğlu M; Marks IM
    Psychother Psychosom; 1996; 65(1):24-28. PubMed ID: 8838693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality traits among panic disorder with agoraphobia patients before and after symptom-focused treatment.
    Hoffart A; Hedley LM
    J Anxiety Disord; 1997; 11(1):77-87. PubMed ID: 9131883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal relationship between dysfunctional beliefs, self-efficacy and panic apprehension in the treatment of panic disorder with agoraphobia.
    Bouchard S; Gauthier J; Nouwen A; Ivers H; Vallières A; Simard S; Fournier T
    J Behav Ther Exp Psychiatry; 2007 Sep; 38(3):275-92. PubMed ID: 17157264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term effectiveness of an empirically supported treatment for agoraphobia.
    Hahlweg K; Fiegenbaum W; Frank M; Schroeder B; von Witzleben I
    J Consult Clin Psychol; 2001 Jun; 69(3):375-82. PubMed ID: 11495167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.